Searched for
ZYDUS LIFE ELUXADOLINE
Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drugZydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week's approval for...- Zydus Life shares rise 2% after USFDA nod for Eluxadoline tabletsZydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) fo...
- Stocks in news: Dr Reddy’s, Shilpa Medicare, Voltas, TCS, Tata MotorsDomestic markets closed slightly lower last week amid mixed global cues. Shares of Dr Reddy’s, Shilpa Medicare, and Tata Motors will be in ...
- Load More